Oncology & Cancer

Testing transgenic T cells against malignant brain tumors

Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.

Oncology & Cancer

Brain cancer linked to nuclear pore alterations

Several types of cancer are believed to be linked to alterations of macromolecular structures known as nuclear pore complexes (NPCs). These structures are embedded in the nuclear envelope, a membrane barrier that separates ...

Oncology & Cancer

Scientists employ AI to predict brain cancer outcomes

Glioblastoma is a swift and aggressive brain cancer, with an average life expectancy of about one year after diagnosis. It's difficult to treat, in part because the cellular makeup of each tumor varies greatly from person ...

page 3 from 39